Literature DB >> 18430751

Transcriptional control of mitochondrial biogenesis: the central role of PGC-1alpha.

Renée Ventura-Clapier1, Anne Garnier, Vladimir Veksler.   

Abstract

Although the concept of energy starvation in the failing heart was proposed decades ago, still very little is known about the origin of energetic failure. Recent advances in molecular biology have started to elucidate the transcriptional events governing mitochondrial biogenesis. In particular, a great step was taken with the discovery that peroxisome proliferator-activated receptor gamma co-activator (PGC-1alpha) is the master regulator of mitochondrial biogenesis. The molecular mechanisms underlying the downregulation of PGC-1alpha and the consequent decrease in mitochondrial function in heart failure are, however, still poorly understood. Indeed, the main pathways involved in mitochondrial biogenesis are thought to be up- rather than down-regulated in pathological hypertrophy and heart failure. The current review summarizes recent advances in this field and is restricted to the heart when cardiac data are available.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18430751     DOI: 10.1093/cvr/cvn098

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  313 in total

Review 1.  The Role of Oxidative Stress and Bioenergetic Dysfunction in Sulfite Oxidase Deficiency: Insights from Animal Models.

Authors:  Angela T S Wyse; Mateus Grings; Moacir Wajner; Guilhian Leipnitz
Journal:  Neurotox Res       Date:  2018-12-05       Impact factor: 3.911

2.  Age-dependent cardiomyopathy in mitochondrial mutator mice is attenuated by overexpression of catalase targeted to mitochondria.

Authors:  Dao-Fu Dai; Tony Chen; Jonathan Wanagat; Michael Laflamme; David J Marcinek; Mary J Emond; Calvin P Ngo; Tomas A Prolla; Peter S Rabinovitch
Journal:  Aging Cell       Date:  2010-04-29       Impact factor: 9.304

3.  A perspective on the determination of mitochondrial biogenesis.

Authors:  Benjamin F Miller; Karyn L Hamilton
Journal:  Am J Physiol Endocrinol Metab       Date:  2011-12-28       Impact factor: 4.310

Review 4.  Novel mitochondrial targets for neuroprotection.

Authors:  Miguel A Perez-Pinzon; R Anne Stetler; Gary Fiskum
Journal:  J Cereb Blood Flow Metab       Date:  2012-03-28       Impact factor: 6.200

5.  Fus1/Tusc2 is a novel regulator of mitochondrial calcium handling, Ca2+-coupled mitochondrial processes, and Ca2+-dependent NFAT and NF-κB pathways in CD4+ T cells.

Authors:  Roman Uzhachenko; Sergey V Ivanov; Wendell G Yarbrough; Anil Shanker; Ruslan Medzhitov; Alla V Ivanova
Journal:  Antioxid Redox Signal       Date:  2014-02-04       Impact factor: 8.401

6.  Effects of maternal diabetes and fetal sex on human placenta mitochondrial biogenesis.

Authors:  Shaoning Jiang; April M Teague; Jeanie B Tryggestad; Christopher E Aston; Timothy Lyons; Steven D Chernausek
Journal:  Placenta       Date:  2017-06-06       Impact factor: 3.481

Review 7.  DNA Damage, DNA Repair, Aging, and Neurodegeneration.

Authors:  Scott Maynard; Evandro Fei Fang; Morten Scheibye-Knudsen; Deborah L Croteau; Vilhelm A Bohr
Journal:  Cold Spring Harb Perspect Med       Date:  2015-09-18       Impact factor: 6.915

Review 8.  Adiponectin: key role and potential target to reverse energy wasting in chronic heart failure.

Authors:  An M Van Berendoncks; Anne Garnier; Renée Ventura-Clapier; Viviane M Conraads
Journal:  Heart Fail Rev       Date:  2013-09       Impact factor: 4.214

9.  Mitofusins 1 and 2 are essential for postnatal metabolic remodeling in heart.

Authors:  Kyriakos N Papanicolaou; Ryosuke Kikuchi; Gladys A Ngoh; Kimberly A Coughlan; Isabel Dominguez; William C Stanley; Kenneth Walsh
Journal:  Circ Res       Date:  2012-08-17       Impact factor: 17.367

Review 10.  Mitochondrial biogenesis as a therapeutic target for traumatic and neurodegenerative CNS diseases.

Authors:  Epiphani C Simmons; Natalie E Scholpa; Rick G Schnellmann
Journal:  Exp Neurol       Date:  2020-04-11       Impact factor: 5.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.